Arkolith/Insider Trading/ACRV/Form 4

Devroe Eric

Chief Operating OfficerAcrivon Therapeutics, Inc. (ACRV) · full profile →Form 4 · filed Jan 15, 2026
Net Buying
Open-Market Buys
$17K
Open-Market Sells
$0
Net Open-Market Flow
$17K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 13, 2026Buy(P)10K$1.72$17K75K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-000212) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML